See All Slides - tctmd.com

Slides

Presentation Advances in Hemodynamic Support 2014

Top 3 Cases with Panel Discussion

Presenter: Samir B. Pancholy

January 23, 2014

Presentation Cell Therapy 2014

Autologous Bone Marrow Cell Administration In Acute Myocardial Infarction

Presenter: Andreas M. Zeiher

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Cardiogenic Shock: Definition of the Syndrome and Goals of Therapy (Including Revascularization)

Presenter: George W. Vetrovec

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

A Prospective: Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 vs. Intra-Aortic Balloon Pump in Patients Undergoing High-Risk PCI: The PROTECT II Study

Presenter: William W. O?Neill

January 23, 2014

Presentation Cell Therapy 2014

MEta-Analysis of Stem Cell Studies (MESS) In Ischemic Heart Disease Using Patient-Specific Data

Presenter: Mariann Gy?ngy?si

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Update on Impella Data with Cardiogenic Shock

Presenter: Jeffrey W. Moses

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Impella® - Keys to Patient Management Beyond the Cath Lab

Presenter: John M. Lasala

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Future Directions of Percutaneous MCS: Clinical Targets and Advanced Technologies

Presenter: N. Uriel

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Expanded Uses of PMCS: Valvuloplasty, Aortic Stenosis and VT

Presenter: Nirat Beohar

January 23, 2014

Presentation Cell Therapy 2014

Bone Marrow Cell Therapy in Acute and Chronic Myocardial Infarction: Insights from Meta-analyses

Presenter: Buddhadeb Dawn

January 23, 2014

Advertisement

Slides

Top 3 Cases with Panel Discussion

Autologous Bone Marrow Cell Administration In Acute Myocardial Infarction

Cardiogenic Shock: Definition of the Syndrome and Goals of Therapy (Including Revascularization)

A Prospective: Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 vs. Intra-Aortic Balloon Pump in Patients Undergoing High-Risk PCI: The PROTECT II Study

MEta-Analysis of Stem Cell Studies (MESS) In Ischemic Heart Disease Using Patient-Specific Data

Update on Impella Data with Cardiogenic Shock

Impella® - Keys to Patient Management Beyond the Cath Lab

Future Directions of Percutaneous MCS: Clinical Targets and Advanced Technologies

Expanded Uses of PMCS: Valvuloplasty, Aortic Stenosis and VT

Bone Marrow Cell Therapy in Acute and Chronic Myocardial Infarction: Insights from Meta-analyses

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content